Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution
The efficacy of a vitamin-E (VE) ophthalmic solution was evaluated on a newly developed rat steroid-induced cataract model. Brown Norway rats irradiated with 2 Gy X-ray, right eyes only, were divided into 5 groups: the control group; 2 steroid (1 mg/kg/day)-treated groups with topic (Top) and system...
Saved in:
Published in | Ophthalmic research Vol. 28 Suppl 2; p. 64 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
01.01.1996
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The efficacy of a vitamin-E (VE) ophthalmic solution was evaluated on a newly developed rat steroid-induced cataract model. Brown Norway rats irradiated with 2 Gy X-ray, right eyes only, were divided into 5 groups: the control group; 2 steroid (1 mg/kg/day)-treated groups with topic (Top) and systemic (Sys) administration, and 2 VE-treated groups, 1 with the same treatment as the Top group with the addition of 5% VE twice a day (Top + VE) and 1 with the same treatment as the Sys group with 5% VE twice a day (SYS + VE). The lens changes were documented with a Scheimpflug camera and changes in light scattering were evaluated quantitatively. The VE-treated groups (Top + VE and Sys + VE) showed a significant inhibition of the increase in the opaque area compared with each of the non-VE-treated groups. The VE ophthalmic solution was strong enough to prevent steroid-induced cataract in rats. |
---|---|
AbstractList | The efficacy of a vitamin-E (VE) ophthalmic solution was evaluated on a newly developed rat steroid-induced cataract model. Brown Norway rats irradiated with 2 Gy X-ray, right eyes only, were divided into 5 groups: the control group; 2 steroid (1 mg/kg/day)-treated groups with topic (Top) and systemic (Sys) administration, and 2 VE-treated groups, 1 with the same treatment as the Top group with the addition of 5% VE twice a day (Top + VE) and 1 with the same treatment as the Sys group with 5% VE twice a day (SYS + VE). The lens changes were documented with a Scheimpflug camera and changes in light scattering were evaluated quantitatively. The VE-treated groups (Top + VE and Sys + VE) showed a significant inhibition of the increase in the opaque area compared with each of the non-VE-treated groups. The VE ophthalmic solution was strong enough to prevent steroid-induced cataract in rats. |
Author | Murano, H Shui, Y B Sasaki, K Kojima, M |
Author_xml | – sequence: 1 givenname: M surname: Kojima fullname: Kojima, M organization: Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan – sequence: 2 givenname: Y B surname: Shui fullname: Shui, Y B – sequence: 3 givenname: H surname: Murano fullname: Murano, H – sequence: 4 givenname: K surname: Sasaki fullname: Sasaki, K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8883091$$D View this record in MEDLINE/PubMed |
BookMark | eNotj09LxDAUxHNYWXdXD34AIV-g-vonaXOUZdWFBS96Xl7TVxppk9KkQr-9EcscBoaZgd-ebayzxNhDCk9pKtQzAGSyVKLasB1ADkleFuUt23v_DRALCrZsW1VVDirdMTrbztQmGGe5a7kPNDnTJMY2s6aGaww4oQ7cWD5h4LSQ5_XCsRmMNT7EbF3-mIAxS07cjV3osB-M5t7181_hjt202Hu6X_3Avl5Pn8f35PLxdj6-XBJdSBGSQpcRoRWNlC1hKSshFBWU1RQZKqFyhXWJQkCULCJkK1UuBCogUaDS2YE9_v-Ocz1Qcx0nM-C0XFfc7BekQlZF |
CitedBy_id | crossref_primary_10_1016_j_colsurfb_2012_10_055 crossref_primary_10_1016_j_freeradbiomed_2021_10_027 crossref_primary_10_1021_la203606z crossref_primary_10_1016_S0022_3549_15_00193_8 crossref_primary_10_1016_S0950_3579_98_80032_0 crossref_primary_10_1016_j_asr_2005_03_135 crossref_primary_10_1016_j_ophtha_2003_04_009 crossref_primary_10_1345_aph_1G271 crossref_primary_10_1016_j_lpm_2012_02_001 crossref_primary_10_1016_j_lssr_2017_07_005 crossref_primary_10_3109_10837450_2015_1078355 crossref_primary_10_1080_01926230701831358 crossref_primary_10_3164_jcbn_35_35 crossref_primary_10_3390_polym13071102 crossref_primary_10_1667_RR1398_1 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1159/000267958 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 8883091 |
Genre | Journal Article |
GroupedDBID | --- .GJ 0~5 0~B 123 29N 30W 329 34G 39C 3O- 3O. 3V. 4.4 53G 5RE 7X7 88E 8AO 8FI 8FJ 8FW 8UI AALGM AAYIC ABJNI ABPAZ ABUWG ACGFS ACNCT ACPRK ACPSR ADAGL ADBBV AENEX AEYAO AFJJK AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BENPR BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF CYUIP DU5 E0A EBS ECM EIF EJD EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HZ~ IAO IHR INH ITC IY7 KUZGX M-- M1P N9A NPM O1H O9- OK1 PQQKQ PROAC PSQYO RIG RKO RXVBD UJ6 UKHRP WH7 ZGI ZXP |
ID | FETCH-LOGICAL-c465t-4c7115f5d66fea768559e4e2be37485939ab7a55050564679f69355a90e54a9c2 |
ISSN | 0030-3747 |
IngestDate | Sat Sep 28 08:51:23 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c465t-4c7115f5d66fea768559e4e2be37485939ab7a55050564679f69355a90e54a9c2 |
PMID | 8883091 |
ParticipantIDs | pubmed_primary_8883091 |
PublicationCentury | 1900 |
PublicationDate | 1996-01-01 |
PublicationDateYYYYMMDD | 1996-01-01 |
PublicationDate_xml | – month: 01 year: 1996 text: 1996-01-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Ophthalmic research |
PublicationTitleAlternate | Ophthalmic Res |
PublicationYear | 1996 |
SSID | ssj0015990 |
Score | 1.5586936 |
Snippet | The efficacy of a vitamin-E (VE) ophthalmic solution was evaluated on a newly developed rat steroid-induced cataract model. Brown Norway rats irradiated with 2... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 64 |
SubjectTerms | Animals Body Weight Cataract - chemically induced Cataract - pathology Cataract - prevention & control Disease Models, Animal Glucocorticoids - toxicity Lens, Crystalline - drug effects Lens, Crystalline - pathology Lens, Crystalline - radiation effects Light Male Ophthalmic Solutions Prednisolone - analogs & derivatives Prednisolone - toxicity Rats Rats, Inbred BN Scattering, Radiation Vitamin E - administration & dosage X-Rays |
Title | Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8883091 |
Volume | 28 Suppl 2 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELagqNVeKmi76gOQD72tTJfEceJjVYF4aOEASNvTyk9t2pKstKES_fUdx85jty0qXKKVrUTefF8mM87MNwh95NZkSqqUaMooodRkRDKtiRVjpoEhlhpX4Dy5YCc39GyaTLt027q6pJIH6tdf60qegiqMAa6uSvYRyLYXhQH4DfjCERCG439hfFrMc5k3Pp-TPChzTSDKvnNf9d3OjKuBqktWRDUy92bpvE2xopfrzvyZVwLGyNGoXMyrufjhEuabpffd18tuOqgEtbvJ5-W3_Fas7K9eze_qXIGvXWtnwFXUzb67oogrsRTfez2xdajJ629BBLMagzFPvXRmY1ajbFQ3Jh1FPfvoFcv_NNsJ93mOEUu5l3Lvwbe4rfGDWD0e-9ZeD06u6WeHmU20mWbOEF647ZzwmSnhPOh2-vUH6SkY_9QuZoCeh0usRR61B3K9jV6G0AF_9jzYQRumeIVeTEJyxGtkOjrg0uI1OuCGDjgvMECPHR2wvMerdHBntnTAHR1wQ4c36Ob46PrLCQldNIiiLKkIVSn8IZtoxqwREF1CDGmoiaRxykMJj7mQqXCBKvjC8NrkljnNfcHHJqGCq2iInhVlYd4iLDlLldVCidjSGN518GjrQwUuYsyzQzt-h4b-Bs0WXiplFu7c-39NfECDjlC7aMvCk2n2wM2r5H4N1W-LqFLh |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+steroid-induced+cataract+in+rat+eyes+by+administration+of+vitamin-E+ophthalmic+solution&rft.jtitle=Ophthalmic+research&rft.au=Kojima%2C+M&rft.au=Shui%2C+Y+B&rft.au=Murano%2C+H&rft.au=Sasaki%2C+K&rft.date=1996-01-01&rft.issn=0030-3747&rft.volume=28+Suppl+2&rft.spage=64&rft_id=info:doi/10.1159%2F000267958&rft_id=info%3Apmid%2F8883091&rft_id=info%3Apmid%2F8883091&rft.externalDocID=8883091 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0030-3747&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0030-3747&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0030-3747&client=summon |